Ignite Creation Date:
2024-05-05 @ 10:05 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001596
Status:
COMPLETED
Last Update Posted:
2017-10-16
First Post:
1999-11-03
Brief Title:
Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
Sponsor:
William Gahl MD
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
970085
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
William Gahl MD
Lead Sponsor Class:
NIH
Responsible Party:
William Gahl MD
Responsible Party Title:
Clinical Director National Human Genome Research Institute
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
National Human Genome Research Institute NHGRI
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Human Genome Research Institute NHGRI | NIH |